Tag: Cancer: Leukemia
Infection Risk Up in Month After CAR T-Cell Immunotherapy
Infection rates increase in patients with ALL aged ≤26 years in first month, then decrease at days 29 to 90
Dexrazoxane Preserves Cardiac Function in Pediatric Leukemia
Beneficial for patients with AML receiving anthracyclines, with no impact on event-free, overall survival
Smoking Tied to Inferior Survival in Acute Myeloid Leukemia
Smoking associated with inferior survival among patients receiving intensive chemotherapy for AML
Prognostic Score Predicts Time to First Treatment in Leukemia
Prognostic score for early-stage CLL based on genetic test, lymphocyte count, lymph node status
Dengue Virus Infection May Increase Risk for Developing Leukemia
Significant link between virus, leukemia risk observed at three to six years after infection
Dasatinib Tops Imatinib for Ph+ Acute Lymphoblastic Leukemia
Four-year cumulative risk of any relapse lower for dasatinib in the context of intensive chemotherapy
Survival Up for Chronic Lymphocytic Leukemia 1995 to 2017
Improvement in median overall survival from 5.8 years in 1995 to 2011 to not reached in 2009 to 2017
Risk Score Developed to Help ID Heart Failure Risk in Leukemia
Risk score identifies risk among patients with acute leukemia treated with anthracyclines before chemo
Testosterone Replacement May Benefit Younger Male Cancer Survivors
Benefits include significant improvement in body composition measurements over six months
Radiation From CT Scans Linked to Thyroid Cancer, Leukemia
Elevated risk stronger in women than men; risk for non-Hodgkin lymphoma increased in patients ≤45
